FDA approves avelumab as maintenance for urothelial carcinomaJuly 1, 2020Genitourinary CancerGynecologic Cancer
FDA approves new indications for pembrolizumabJuly 1, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Personalized cancer vaccine may enhance checkpoint inhibitor activityJune 25, 2020ImmunotherapyBreast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersMelanoma
Higher death risk with minimally invasive surgery in gynecologic cancersJune 23, 2020Gynecologic Cancer
‘Hospital at home’ cuts ED visits and costs for cancer patientsJune 12, 2020Patient & Survivor CareGastroenterologyGynecologic CancerGenitourinary CancerLung CancerASCO Lung CancerGastrointestinal Cancer
American Cancer Society update: ‘It is best not to drink alcohol’June 9, 2020Preventive CareBreast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
Can an app guide cancer treatment decisions during the pandemic?June 9, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerCOVID-19 UpdatesGastroenterologyGenitourinary CancerGynecologic Cancer
‘A good and peaceful death’: Cancer hospice during the pandemicJune 5, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Germline testing in advanced cancer can lead to targeted treatmentJune 3, 2020Mixed TopicsBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Moving on up: Maintenance therapy extends OS in bladder cancerMay 29, 2020Genitourinary CancerGynecologic Cancer
Should all patients with advanced ovarian cancer receive frontline maintenance therapy?May 27, 2020Gynecologic Cancer
